Publications by authors named "Rosemarie Cepeda"

Claim this Profile
T
The Discovery of N-(1-Methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl)-5-((6- ((methylamino)methyl)pyrimidin-4-yl)oxy)-1H-indole-1-carboxamide (Acrizanib), a VEGFR-2 Inhibitor Specifically Designed for Topical Ocular Delivery, as a Therapy for Neovascular Age-Related Macular Degeneration.
Christopher M Adams, Karen Anderson, Gerald Artman, Jean-Claude Bizec, Rosemarie Cepeda

J Med Chem· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of involvement of CEP adducts in TLR activation and in angiogenesis.
John Gounarides, Jennifer S Cobb, Jing Zhou, Frank Cook, Xuemei Yang, Rosemarie Cepeda

PLoS One· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Oral VEGFR-2 Inhibitors with Prolonged Ocular Retention That Are Efficacious in Models of Wet Age-Related Macular Degeneration.
Erik L Meredith, Nello Mainolfi, Stephen Poor, Yubin Qiu, Karl Miranda, Rosemarie Cepeda

J Med Chem· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacologic uncoupling of angiogenesis and inflammation during initiation of pathological corneal neovascularization.
Jeremy M Sivak, Allison C Ostriker, Amber Woolfenden, John Demirs, Rosemarie Cepeda

J Biol Chem· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age-dependent incidence, time course, and consequences of thymic renewal in adults.
Frances T Hakim, Sarfraz A Memon, Rosemarie Cepeda, Elizabeth C Jones, Catherine K Chow

J Clin Invest· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis